MCM5 was also highly expressed in many tumors, such as thyroid cancer cells (Mio et al., 2016) and breast cancer (Eissa et al., 2015), but its expression status and prognostic value in lung cancer have yet to be evaluated. The gene discussed is MCM5; the disease is breast carcinoma.